Amyris, Inc. short interest in 2019
In 2019, Amyris, Inc.'s disclosed short interest ran from 13.51% of shares outstanding on 15 Jan 2019 to 16.62% on 31 Dec 2019, a change of +3.11 percentage points. The year's high was 24.46% on 29 Mar 2019 and its low 10.18% on 30 Sep 2019, averaging 15.39% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.91 days on 15 Jul 2019. Full history: Amyris, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2019 in figures
- Start of year
- 13.51% (15 Jan 2019)
- End of year
- 16.62% (31 Dec 2019)
- Change
- +3.11 pp
- High
- 24.46% (29 Mar 2019)
- Low
- 10.18% (30 Sep 2019)
- Average
- 15.39%
- Highest days to cover
- 25.91 (15 Jul 2019)
- SEC filings marked
- 7
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 13.51% | 12.75 | |
| 31 Jan 2019 | 13.22% | 10.48 | |
| 15 Feb 2019 | 17.06% | 1.32 | |
| 28 Feb 2019 | 18.37% | 7.23 | |
| 15 Mar 2019 | 19.25% | 11.28 | |
| 29 Mar 2019 | 24.46% | 3.17 | results (8-K) |
| 15 Apr 2019 | 20.59% | 2.78 | results (8-K) |
| 30 Apr 2019 | 12.54% | 2.37 | |
| 15 May 2019 | 14.42% | 8.43 | |
| 31 May 2019 | 15.66% | 11.94 | |
| 14 Jun 2019 | 15.36% | 19.36 | |
| 28 Jun 2019 | 15.72% | 15.20 | |
| 15 Jul 2019 | 15.54% | 25.91 | |
| 31 Jul 2019 | 14.84% | 13.65 | |
| 30 Sep 2019 | 10.18% | 12.58 | |
| 15 Oct 2019 | 12.03% | 11.39 | 10-K filed, results (8-K), 10-Q filed |
| 31 Oct 2019 | 11.92% | 23.84 | |
| 15 Nov 2019 | 12.95% | 15.75 | results (8-K), 10-Q filed |
| 29 Nov 2019 | 14.04% | 17.92 | |
| 13 Dec 2019 | 14.88% | 12.02 | |
| 31 Dec 2019 | 16.62% | 15.17 |
See also: Amyris, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.